SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-211458
Filing Date
2023-08-14
Accepted
2023-08-14 07:30:59
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d499757d10q.htm   iXBRL 10-Q 943096
2 EX-3.1 d499757dex31.htm EX-3.1 8903
3 EX-31.1 d499757dex311.htm EX-31.1 10338
4 EX-31.2 d499757dex312.htm EX-31.2 10354
5 EX-32.1 d499757dex321.htm EX-32.1 4105
6 EX-32.2 d499757dex322.htm EX-32.2 4124
  Complete submission text file 0001193125-23-211458.txt   5717098

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230630.xsd EX-101.SCH 54127
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE txmd-20230630_cal.xml EX-101.CAL 56522
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE txmd-20230630_def.xml EX-101.DEF 232893
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230630_lab.xml EX-101.LAB 417951
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230630_pre.xml EX-101.PRE 351563
62 EXTRACTED XBRL INSTANCE DOCUMENT d499757d10q_htm.xml XML 863747
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 231166270
SIC: 2834 Pharmaceutical Preparations